Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML

We sought to identify drugs that could counteract cytarabine resistance in acute myeloid leukemia (AML) by generating eight resistant variants from MOLM-13 and SHI-1 AML cell lines by long-term drug treatment. These cells were compared with 66 ex vivo chemorefractory samples from cytarabine-treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Malani, D, Murumägi, A, Yadav, B, Kontro, M, Eldfors, S, Kumar, A, Karjalainen, R, Majumder, M M, Ojamies, P, Pemovska, T, Wennerberg, K, Heckman, C, Porkka, K, Wolf, M, Aittokallio, T, Kallioniemi, O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420795/
https://www.ncbi.nlm.nih.gov/pubmed/27833094
http://dx.doi.org/10.1038/leu.2016.314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420795/
https://www.ncbi.nlm.nih.gov/pubmed/27833094
http://dx.doi.org/10.1038/leu.2016.314

Ejemplares similares